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Abstract
Background Families and friends provide a considerable proportion of care for patients and elderly people. Caregiving 
can have substantial effects on caregivers’ lives, health, and well-being. However, because clinical trials rarely assess these 
effects, no information on caregiver burden is available when evaluating the cost effectiveness of treatments.
Objective This study develops an algorithm for estimating caregiver time using information that is typically available in 
clinical trials: the EQ-5D scores of patients and their gender.
Methods Four datasets with a total of 8012 observations of dyads of caregivers and a gamma model with a log-link esti-
mated with the Bayesian approach were used to estimate the statistical association between patient scores on the EQ-5D-3L 
dimensions and the numbers of hours of care provided by caregivers during the previous week. The model predicts hours of 
care as mean point estimates with 95% credible intervals or entire distributions.
Results Model predictions of hours of care based on the five EQ-5D dimensions ranged from 13.06 (12.7–14.5) h/week for 
female patients reporting no health problems but receiving informal care to 52.82 (39.38–66.26) for male patients with the 
highest level of problems on all EQ-5D dimensions.
Conclusions The iCARE algorithm developed in this study allows researchers who only have patient-level EQ-5D data to 
estimate the mean hours of informal care received per week, including a 95% Bayesian credible interval. Caregiver time can 
be multiplied with a monetary value for caregiving, enabling the inclusion of informal care costs in economic evaluations. 
We recommend using the tool for samples that fall within the confidence intervals of the characteristics of our samples: men 
(age range 47.0–104.2 years), women (age range 55–103 years).
Key Points for Decision Makers 
Including caregiving costs in economic evaluations 
is necessary in order to avoid the risk of labelling an 
intervention as cost effective when it actually does not 
maximize social welfare.
The iCARE tool (https ://www.imta.nl/tools /) can be used 
to include informal care in economic evaluations based 
on patients’ EQ-5D data in situations where it is not 
feasible to collect caregiver data.
The iCARE tool enables the inclusion of informal care 
on the cost side of economic evaluations and should 
be used for samples that fall within the following age 
ranges: men (47–104.2 years), women (55–103 years).
Electronic supplementary material The online version of this 
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1 Introduction
Economic evaluations in healthcare provide decision makers 
with insights about the relative efficiency of different inter-
ventions for producing health. These evaluations compare 
incremental costs and effects, often expressed in terms of 
quality-adjusted life-years, to some threshold representing 
either societal willingness to pay or opportunity costs within 
the healthcare system. An important consideration in these 
evaluations concerns the types of costs and effects that are 
to be included in the analysis [1, 2]. Advocates of a ‘soci-
etal perspective’ propose that all costs and effects occurring 
in society at large need to be considered [3, 4], including 
those associated with informal caregiving [5–10]. Moreover, 
excluding informal care in economic evaluations can result 
in non-optimal healthcare decision making [6, 11].
Family and friends often provide a substantial number 
of hours of care per week to address patients’ care needs 
[12, 13]. Therefore, healthcare interventions can affect not 
only patients but also the individuals in their social network 
[14–18]. A patient’s health can directly influence the health 
and well-being of the patient’s family or friends, regardless 
of whether they are involved in caregiving [19–22]. In addi-
tion to this family effect of ill health, family members and 
friends can experience positive and negative consequences 
from providing care, known as the caregiving effect [22]. For 
example, many caregivers derive fulfilment from caregiving, 
but caregiving is also associated with depressive feelings 
and physical health problems, and it can be difficult to com-
bine caregiving with other activities, such as paid work or 
family life [23–26].
Outcomes for caregivers can be included on either the 
effect side or the cost side in economic evaluations. On the 
effect side, caregiver outcomes can be included as health-
related quality of life next to patients’ utilities in cost-utility 
analysis or as a separate outcome in terms of care-related 
quality of life or carer experiences in multi-criteria analysis 
[27, 28]. Alternatively, informal care can be addressed as 
one of the cost components in economic evaluations in the 
form of the opportunity costs of the time spent on caregiv-
ing, typically by multiplying caregivers’ time investment 
by a value for time [6, 11]. However, due to practical con-
siderations and methodological difficulties in identifying, 
measuring, and valuing informal care, these costs are usually 
not included in economic evaluations [6, 11, 29], mainly 
because most clinical and observational studies only col-
lect data about patients and not about their caregivers [17]. 
Because effects of interventions on carers are not usually 
measured, they remain unknown [6], potentially resulting in 
suboptimal resource allocation recommendations.
Recent research has attempted to predict caregiver out-
comes using patient health data—for example, researchers 
have used data collected for measuring the family impact 
of meningitis to estimate changes in carers’ health based 
on changes in patients’ health [30], and have also focused 
on predicting parents’ health-related quality of life 
based on health information about their ill children [31]. 
Although these studies provide compelling examples of 
how to include caregivers’ health-related quality of life 
data in economic evaluations, they are rather restrictive 
in the type of data they use, and they also report poor 
predictive performance for their statistical models. In addi-
tion to these findings, we also investigated the relation-
ship between care-related quality-of-life data of caregivers 
using the CarerQol instrument (CarerQol-7D) [27] and 
patient-level data, but we found this relationship to be very 
weak. To overcome some of these challenges, studies have 
proposed accounting for informal care on the cost side. For 
example, some studies [3, 32] have developed statistical 
models for predicting the number of days of care using 
patients’ health data. However, using the number of days 
of care can only provide a general indication of the real 
informal care costs, since the actual time commitment on 
each day remains unknown.
This study aimed to develop a statistical model for pre-
dicting caregivers’ time investment using patients’ health 
data, to serve as an input for cost calculations in economic 
evaluations. The study builds on previous research in several 
ways. First, we combined several datasets that contain health 
data for a large variety of patient groups in the Netherlands. 
This allowed more generalizable results and made it pos-
sible to develop a platform that can be used for accounting 
for informal care in various economic evaluations. Second, 
we measured informal care costs based on the hours of care 
during a week rather than days per week, as in previous 
research, which provides a more accurate indication of infor-
mal care costs. Moreover, we used caregiver-reported time 
investment, while previous research used patients’ reports of 
their caregivers’ time investment [3, 32]. Hence, we aimed 
to develop a prediction model for the number of hours of 
care received by the patient based on information that is 
routinely available in clinical studies: the health status as 
measured by the EQ-5D and the gender of the patient. A 
unique feature of our study is that, based on our predic-
tion model, we have constructed a Microsoft Excel tool, the 
informal CARE effect (iCARE) tool (https ://www.imta.nl/
tools /), which researchers can use to estimate hours of care 
in the absence of data on caregivers. The prediction model 
and the iCARE tool enable the inclusion of informal care on 
the cost side of economic evaluations that only have access 
to patient health data as measured by the EQ-5D.
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2  Methods
2.1  Data
This study used 4 survey datasets with a total of 8012 obser-
vations. Here we briefly describe the datasets; the appendix 
provides a more thorough description (see electronic sup-
plementary material [ESM]). Our dataset 1 (n = 6482) is the 
Older Persons and Informal Caregivers Survey Minimum 
Data Set (TOPICS-MDS, http://www.topic s-mds.eu), a data-
base of 26 research projects on care for older persons in the 
Netherlands that is part of the National Care for the Elderly 
Programme (NPO) [33, 34]. Dataset 2 (n = 1244) concerns 
a heterogeneous group of informal caregivers selected from 
a representative sample in terms of age and gender of the 
Netherlands’ general population aged 18 years and over [35]. 
Dataset 3 (n = 175) was collected with written question-
naires from a heterogeneous group of informal caregivers 
identified through respite centres in the Netherlands in 2003 
[28]. Dataset 4 (n = 111) comes from the Brabant Injury 
Outcome Surveillance (BIOS) study, a cohort study of hip 
fracture patients in the Netherlands [36].
In all four datasets, health status was measured with 
the three-level version of the EuroQoL-5D measure (EQ-
5D-3L) developed by the EuroQol Group (http://www.euroq 
ol.org [37]), the most commonly used measure of patient 
health status in economic evaluations and the instrument of 
choice of the National Institute for Health Care and Excel-
lence (NICE) for supporting reimbursement decisions [38]. 
Responses to the EQ-5D-3L questionnaire were provided 
by either the patients themselves (datasets 1 and 4) or their 
caregivers (datasets 2 and 3). Depending on the dataset, 
different questions were used to gather information on the 
number of informal care hours per week. For datasets 1, 2 
and 3, information on the hours of informal caregiving was 
collected through questions on care activities from the iMTA 
Valuation of Informal Care Questionnaire (iVICQ [39]). For 
datasets 1 and 2, three questions were posed regarding the 
number of informal care hours during the previous week 
that were spent on household activities (HDL), personal care 
activities (ADL) and practical support (IADL). In dataset 
3, these three different types of activities were split into 16 
different care tasks (e.g. preparing food, personal hygiene). 
In dataset 4, information was collected on six care activities 
covering HDL, ADL and IADL activities. In all datasets, 
the total number of informal caregiving hours indicates the 
sum of the hours spent on HDL, ADL, and IADL activities 
during the preceding week. The maximum number of hours 
of care was set to 126 h/week [27] because, although some 
caregivers report needing to be on standby 24/7 for care 
needs, caregivers also need time for other activities, such as 
their own personal care or sleep.
Table 1 describes the four datasets and shows that they 
differ in terms of sample size, age of the care receivers, 
health of the care receivers as indicated by the EQ-5D-3L, 
and mean number of hours of care provided by the caregiver. 
Figure 1 presents histograms of the number of hours of 
informal care reported for the previous week in each data-
set. We observe that the distribution is positively and right 
skewed for all datasets. All patients in the analysis reported 
that they received informal care during the previous week. 
Nonetheless, in some instances, their caregivers reported 
having provided zero hours of care during the preceding 
week.
2.2  Analyses
We developed our model, which predicts the number of 
hours of informal care based on the EQ-5D-3L items, in 
four steps. In step 1, we selected the best regression method 
for our model. In step 2, we pooled the four datasets and 
selected the best model specification for the data (includ-
ing testing for interaction terms). In step 3, we estimated 
the model developed in steps 1 and 2 using the Bayesian 
approach. Finally, in step 4, we used the results from the 
Bayesian estimation to develop the iCARE tool, which pre-
dicts hours of care (i.e., point estimates for the mean and 
the entire distribution of 10,000 samples obtained from the 
Markov chain Monte Carlo [MCMC] simulation). We used 
the library gamlss in R [40, 41] in steps 1 and 2, and we used 
Winbugs [42] in step 3. Here we briefly describe each step; 
details appear in the appendix (see ESM).
In step 1, we compared the linear and gamma models 
using training and validation sets obtained from the four 
datasets. At this stage, we modelled the number of hours of 
care as a function of gender and the EQ-5D-3L items. To 
do this, we randomly trained the model on a pooled dataset 
formed by collapsing three datasets and then validated this 
model with the remaining dataset (the four datasets provided 
four such training and validation sets). We also developed 
a training and validation set by splitting the pooled dataset 
obtained from merging the four datasets in half, through 
random sampling. To assess the quality of the prediction, we 
used the mean absolute error (MAE), the mean square error 
(MSE), the root mean square error (RMSE) [43] and the 
original Akaike information criterion (AIC) [44] for model 
comparison. We developed regression models both with and 
without intercepts. Although models without an intercept 
are generally not recommended, as they can introduce bias 
[45], they are appealing for our setting since it seems rea-
sonable to assume that an individual in full or perfect health 
as indicated by the best EQ-5D-3L state may require 0 h of 
informal care. However, we found that the gamma model 
with an intercept produced the smallest prediction error (see 
Appendix Table 2 in the ESM).
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In step 2, we pooled the four datasets and used the gamma 
method to select the best model specification by compar-
ing models, including interaction terms for both the mean 
and the scale parameters of the gamma models. We mini-
mized the generalized AIC (GAIC) for different penalties: 
GAIC = − 2 ∗ l(휃) + df ∗ # , where − 2 ∗ l(휃) is the fitted 
deviance, df denotes the total degrees of freedom, and # is 
the penalty for each degree of freedom used in the model 
[41, 46]. We selected the model specification based on the 
GAIC with penalties # = 2, 5, 9 ; # = 2 produces the original 
AIC [44], # = 9 gives the Schwarz Bayesian information 
criterion (SBC), and we also considered the GAIC with a 
penalty of 5, a value falling between the AIC and the SBC. 
We found that the best model specification as indicated by 
the GAIC with various penalties is one in which the shape 
parameter is modelled as a log-link function of the EQ-
5D-3L dummy variables and the gender of the patient (see 
Appendix Table 3 in the ESM). In fact, because gender as 
a main effect as well as in interaction with other variables 
produced large benefits in terms of model fit, we opted to 
fit separate models for men and women. We found that no 
other interactions were significant and that adding model 
specifications for the scale parameter did not significantly 
improve the model fit.
To develop a model that provides predictions while 
offering a suitable measure of uncertainty associated with 
unknown future events, we used a Bayesian approach in step 
3 to estimate probability distributions over future events. 
We used the MCMC algorithm, which yielded a Monte 
Carlo sample from the posterior predictive distribution over 
future quantities. We used the Bayesian estimates in step 4 
to develop the iCARE tool, which predicts hours of informal 
care for a caregiver using the patient’s EQ-5D-3L data. The 
tool includes estimations of hours of informal care based on 
both EQ-5D-3L and EQ-5D-5L data, where the 5L data are 
transformed to 3L data using the probability matrix from 
the 5L to 3L cross-walk [47]. Note that the predictions of 
caregivers’ hours of informal care are based on a sample of 
individuals who all receive care. Since, in many populations, 
not all individuals receive care, the estimate produced by the 
toolkit must be corrected for the proportion of patients that 
receive care before using the estimate in cost-effectiveness 









All four datasets (n = 8012)
Men Women Men Women Men Women Men Women Men and women
Number of observations 2310 4172 421 823 88 87 28 83 8012
Minimum number of hours of care 0 0 1 1 0 0 3 0.5 0
Mean number of hours of care 19.8 14.1 21.6 16.7 41.9 30.9 42 37.9 17.3
Maximum number of hours of care 126 126 126 126 111.8 126 108 126 126
Minimum age (year) of care receiver 54 55 2 1 6 8 65.1 66.4 1
Mean age (year) of care receiver 79.3 81.4 56.9 67.3 66 72.1 77.4 80.2 77.8
Maximum age (year) of care receiver 98 103 99 99 100 95 95.1 97.1 103
% with 0 h of care 1 0.86 0 0 1.14 1.15 0 0 0.76
% with 126 h of care 1.56 0.6 0.95 0.61 0 1.15 0 1.2 0.9
EQ-5D items
% Mobility 1 (no problems) 28 24 33 19 17 16 43 44 26
% Mobility 2 (some problems) 68 71 59 73 66 63 57 54 69
% Mobility 3 (a lot of problems) 4 5 8 8 17 21 0 2 5
% Anxiety 1 (no problems) 67 63 44 47 27 23 71 75 61
% Anxiety 2 (some problems) 29 32 42 43 58 56 29 19 33
% Anxiety 3 (a lot of problems) 4 5 14 10 15 21 0 6 6
% Self care 1 (no problems) 57 58 41 40 23 19 78 63 54
% Self care 2 (some problems) 31 29 42 45 38 41 18 27 32
% Self care 3 (a lot of problems) 12 13 17 15 39 40 4 10 14
% Daily activities 1 (no problems) 43 38 20 15 7 1 57 48 35
% Daily activities 2 (some problems) 39 45 54 60 35 37 36 40 45
% Daily activities 3 (a lot of problems) 18 17 26 25 58 62 7 12 20
% Pain 1 (no pain) 46 33 35 21 22 24 64 54 35
% Pain 2 (some pain) 45 53 48 56 61 62 36 39 51
% Pain 3 (a lot of pain) 9 14 17 23 17 14 0 7 14
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analyses. To further exemplify its use, below we apply the 
toolkit to a previously published cost-effectiveness model for 
multiple sclerosis and demonstrate the impact of including 
caregiver burden on the incremental cost-effectiveness ratio.
3  Results
Figure 2 shows posterior distributions of the 10,000 MCMC 
simulation samples for the regression coefficients of the 
mean hours of care (µ), modelled separately for male and 
female patients. The regression coefficients consist of an 
intercept and EQ-5D-3L responses at levels 2 (some prob-
lems) and 3 (a lot of problems) relative to the baseline level 
1 (no problems) for each EQ-5D-3L question. The distri-
butions of the regression coefficients estimated for level 3 
relative to level 1 were wider (illustrating more variation or 
higher uncertainty) and shifted to the right compared with 
those estimated for level 2 relative to level 1. For some EQ-
5D-3L items, the two distributions largely overlapped. In 
the model for men, the EQ-5D-3L estimates for levels 2 
and 3 overlapped for anxiety, mobility, and pain, while they 
overlapped for anxiety and self-care in the model for women. 
In general, the relationship between the hours of informal 
care and the EQ-5D-3L score was stronger for men than for 
women.
Table 2 illustrates the summary regression coefficient 
estimates (mean with 95% credible intervals, median, MC 
error) based on the 10,000 MCMC sample distributions. 
Table 2 shows that, for both men and women, the coefficients 
at levels 2 and 3 for most EQ-5D-3L questions had a posi-
tive sign relative to the item responses indicated at level 1, 
suggesting that the number of informal care hours increased 
as the health state indicated by the EQ-5D-3L score wors-
ened. There are exceptions for a few coefficients at level 2, 
which had a negative sign relative to level 1 (usual activities 
for men and pain for women); however, these coefficients 
were not statistically significant and, as indicated by Fig. 2, 
their posterior distributions overlapped with the coefficient 
distributions at level 3. Moreover, in both models (men and 
women), the coefficient for mobility at level 2 was negative, 
which means that our models cannot distinguish between 
mobility levels 1 and 2. For these situations, we considered 
levels 1 and 2 as interchangeable in the iCARE tool and 
included only changes of level 1 or level 2 relative to level 3.
Figure 3 compares posterior hours-of-care predictions 
(distribution and mean) for individuals in the best health 
state (11111) and in the worst health state (33333), as 
Fig. 1  Histograms of the four 
datasets
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Fig. 2  Posterior distributions (10,000 MCMC samples) of the regression coefficients of the mean µ for the models for male patients (top) and 
for female patients (bottom). Coefficients for the EQ-5D item levels 2 (grey lines) and 3 (black lines) are relative to the baseline category level 1
Table 2  Posterior summary 
estimates of the regression 
coefficients for the mean µ on 
log-link scale
MC Monte Carlo, SD standard deviation
*Significant; credible interval does not include zero
Coefficient Mean SD MC error 2.50% Median 97.50%
Model for male patients
bm
0
 (intercept) 3.0070* 0.0205 0.0002 2.9660 3.0070 3.0470
bm
1
 (ACT2) − 0.0048 0.0500 0.0005 − 0.1019 − 0.0051 0.0940
bm
2
 (ACT3) 0.2228* 0.0655 0.0008 0.0935 0.2233 0.3513
bm
3
 (ANX2) 0.1205* 0.0464 0.0005 0.0312 0.1202 0.2127
bm
4
 (ANX3) 0.2298* 0.0929 0.0009 0.0515 0.2285 0.4147
bm
5
 (SC2) 0.2307* 0.0498 0.0005 0.1329 0.2310 0.3266
bm
6
 (SC3) 0.4622* 0.0748 0.0008 0.3144 0.4621 0.6078
bm
7
 (MO2) − 0.1030* 0.0504 0.0006 − 0.2022 − 0.1032 − 0.0022
bm
8
 (MO3) 0.0728 0.1094 0.0013 − 0.1386 0.0738 0.2857
bm
9
 (PAIN2) 0.1013* 0.0463 0.0005 0.0109 0.1008 0.1925
bm
10
 (PAIN3) 0.1969* 0.0741 0.0008 0.0523 0.1961 0.3444
Model for female patients
bw
0
 (intercept) 2.7010* 0.0143 0.0002 26.730 27.010 27.290
bw
1
 (ACT2) 0.0494 0.0359 0.0005 − 0.0214 0.0497 0.1184
bw
2
 (ACT3) 0.3071* 0.0493 0.0006 0.2124 0.3070 0.4032
bw
3
 (ANX2) 0.0119 0.0324 0.0003 − 0.0516 0.0115 0.0763
bw
4
 (ANX3) 0.0584 0.0628 0.0007 − 0.0619 0.0585 0.1831
bw
5
 (SC2) 0.1955* 0.0355 0.0005 0.1260 0.1953 0.2638
bw
6
 (SC3) 0.1643* 0.0524 0.0007 0.0640 0.1640 0.2682
bw
7
 (MO2) − 0.1527* 0.0392 0.0005 − 0.2303 − 0.1526 − 0.0778
bw
8
 (MO3) 0.1611* 0.0789 0.0008 0.0071 0.1610 0.3141
bw
9
 (PAIN2) − 0.0052 0.0345 0.0004 − 0.0721 − 0.0051 0.0616
bw
10
 (PAIN3) 0.1102* 0.0491 0.0005 0.0164 0.1095 0.2076
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indicated by the EQ-5D-3L instrument. For male patients, 
the predictions of the mean hours of informal care per week 
varied between 16.0 (95% CI 14.7–17.4) and 52.8 (95% CI 
39.4–66.3) for the best (11111) and the worst (33333) health 
state. For female patients, the variation was between 13.6 
(95% CI 12.7–14.5) for the best (11111) and 32.0 (95% CI 
26.2–37.8) for the worst (33333) health state. Hence, in line 
with the raw dataset, the numbers of hours of informal care 
predicted for men were considerably greater than for women.
We imported the estimated probability distributions using 
the Bayesian approach from Winbugs to Microsoft Excel and 
developed the iCARE tool to provide users with entire esti-
mated probability distribution predictions and corresponding 
point estimates of the mean hours of informal care based on 
the EQ-5D-3L items, with 95% credible intervals.
We used the iCARE tool in a case study to estimate car-
egiver burden for multiple sclerosis (MS) patients, using data 
from a previously published cost-effectiveness model [48]. 
The model had four health states based on the Expanded 
Disability Status Scale (EDSS): EDSS1 (EDSS 0–2.5), 
EDSS2 (EDSS 3–5.5), EDSS3 (EDSS 6–7.5), and EDSS4 
(EDSS 8–9.5), and two relapse states. Observed EQ-5D-3L 
data for patients in each of the four EDSS-based health states 
(n = 1295) were available, and we used these to calculate 
caregiver hours per week for each health state. Since not all 
of the MS patients received informal care (especially those 
in the better EDSS states), and the iCARE algorithm is based 
on a sample of patients who all receive care, the estimated 
values had to be corrected for the proportion of patients who 
received care. For this, we used values for the proportion of 
patients in each EDSS class who receive care as provided 
in [49]. We translated the resulting estimate into costs per 
month using a 14 Euro (€) per hour cost price for caregiver 
time, as recommended in the Dutch costing manual [50]. 
The reference price of 1 h of informal care here is the mar-
ket value of household activities as stated by the Central 
Administration Office (CAK) in the Netherlands. Costs and 
effects were discounted by 3% annually. Table 3 shows that 
including caregiver burden in this example reduces the life-
time incremental costs of glatiramer acetate versus symptom 
Fig. 3  Posterior predictions 
of mean hours of informal 
care for the best and the worst 
health states as indicated by the 
EQ-5D. The large dots represent 
the posterior mean distribution 
estimates
Table 3  Example application incorporating estimated caregiver burden (monthly caregiver costs)
EDSS Expanded Disability Status Scale, ICER Incremental cost effectiveness ratio, SD standard deviation
a Based on Uitdehaag et al. [49]
Health state 1 (EDSS 0–2.5) 2 (EDSS 3–5.5) 3 (EDSS 6–7.5) 4 (EDSS 8–9.5) Relapse 1 Relapse 2
Mean EQ-5D utility (Dutch tariff) 0.74 0.63 0.52 0.33 0.65 0.54
N 371 557 278 19
Hours per week 15.03 15.68 16.96 23.59
Hours per month 60.12 62.73 67.84 94.355
Proportion receiving informal  carea 22% 58% 58% 75%
Costs per month €186.00 €508 €549 €990.73 Equal to EDSS2 Equal to EDSS3
SD costs per month €37.10 €190.27 €212.54 €321.33
ICER without estimated informal 
care
€161,319
ICER with estimated informal care €145,265
 M. Gheorghe et al.
management from €22.369 to €20.774; consequently, the 
incremental cost-effective ratio (ICER) was reduced by 
approximately 10% (from €161.319 to €145.265).
4  Discussion
This study shows that the relationship between the number 
of hours of care indicated by a caregiver and the EQ-5D-3L 
score of the care receiver can successfully be used to develop 
a prediction model that estimates informal care effects for 
economic evaluations in clinical studies when these data are 
unavailable. We developed the iCARE tool to derive predic-
tions (mean, 95% credible intervals and entire distributions 
based on 10,000 MCMC samples) of hours of informal care 
using patient-level EQ-5D-3L data.
Our results show that informal care effects are higher for 
patients with lower health scores, in line with findings of 
previous studies [3, 32]. Moreover, our results indicate that 
men required more hours of informal care than women. The 
predicted mean hours of informal care per week for male 
patients varied between 16.0 (95% CI 14.7–17.4) for the best 
(11111) and 52.8 (95% CI 39.4–66.3) for the worst (33333) 
EQ-5D-3L health state. For female patients, the variation 
was between 13.6 (95% CI 12.7–14.5) for the best (11111) 
and 32.0 (95% CI 26.2–37.8) for the worst (33333) health 
state.
Our study has several noteworthy strengths. First, it 
contributes to the economic evaluation field by enabling 
researchers to estimate the effects of interventions on 
informal carers. Considering the increasing appeal to the 
public in many countries to contribute to the care of their 
loved ones, it is important to account for the effects thereof, 
irrespective of the perspective adopted in the evaluation 
of healthcare interventions. It is evident that these effects 
should be included in evaluations from the societal perspec-
tive. But considering the mounting evidence of the effects 
of providing care on the health and wellbeing of informal 
caregivers, evaluations from a healthcare perspective should 
also consider examining and presenting these effects along-
side the health effects of interventions on patients. After 
obtaining information on the hours of informal care using 
the iCARE tool and correcting this estimate for the propor-
tion of the sample that is receiving care, the next step for 
researchers is to multiply the hours of informal care by a 
value for time spent on informal care. This value can be 
derived from health economic manuals or the literature; for 
example, by using the value of a close market substitute who 
could be hired to perform the specific caregiving tasks [51] 
or values from stated preference methods, such as contingent 
valuation studies or discrete choice experiments [27, 51–53]. 
Second, from a statistical perspective, we have addressed 
some important challenges associated with the development 
of the prediction model. We used a variety of datasets in 
this study that include information on hours of care and the 
EQ-5D-3L items, allowing us to test the robustness of the 
prediction models for various populations. Furthermore, 
we adopted a Bayesian estimation procedure that enabled 
us to obtain suitable measures of uncertainty through use 
of the MCMC algorithms. This is important, especially for 
using the prediction model results in economic evaluations, 
as it will allow proper propagation of uncertainty in these 
models.
Our study also has several limitations. First, some of 
the datasets did not provide self-completed information on 
the care receiver’s EQ-5D-3L: for two of the four datasets, 
accounting for about 18% of the pooled dataset used to 
estimate the prediction model, the EQ-5D-3L question-
naire was completed by the caregiver instead of the care 
receiver, which may have introduced bias in our analyses. 
Second, we only had data on the hours provided by the 
primary caregiver, while patients could have had more 
than just one caregiver and hence may have received more 
hours of care in total. The model we developed is not con-
ditional on the number of caregivers that a patient might 
have had but only on patient gender and EQ-5D-3L items. 
This means that the estimated number of hours of care 
from the model is independent of the number of caregiv-
ers. Third, the four datasets are rather unbalanced in terms 
of sample size, as they represented 81%, 15.5%, 2.1%, and 
1.4% of the pooled dataset. Obviously, the pooled esti-
mate was dominated by the larger dataset (TOPICS). This 
might have cancelled some of the diversity introduced by 
the different datasets, although the largest dataset com-
prised 26 different studies in a variety of patient popula-
tions. However, the pooled databases, while adding more 
heterogeneity, result in a model with similar errors and 
increased variability (or range of model predictions) as 
the one using TOPICS data only, and this is potentially 
beneficial for developing a toolkit that could be used in 
diverse health technology assessments. Fourth, the model 
is based on data from the Netherlands only. The validity 
of the model’s predictions for other countries with differ-
ent healthcare systems and perhaps different informal car-
egiving needs and traditions is therefore unclear. Hence, 
we recommend investigating country-specific tools using 
local data. Fifth, we purposefully restricted the prediction 
model to information that is routinely available in clinical 
studies. Including only patient EQ-5D and gender was an 
a priori decision made considering that the main purpose 
of the tool was to be used in studies in which no informa-
tion about the caregiving is available. More often than not, 
information about the caregiver is not available in clini-
cal trials and observational studies; hence, we focused on 
developing a tool that would be useful in studies where 
only patient data is available. Besides, we expect that in 
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studies where information about the caregiver is collected, 
this will likely include information about hours of care 
and there would therefore be no use for this tool. We also 
developed models including the relationship between the 
number of hours of care and the age of the patient; how-
ever, we found that this was difficult to explain and did 
not improve model fit. In addition, we developed models 
including other explanatory variables such as relation-
ship of the care receiver with the caregiver (partner, son/
daughter, other), age of the caregiver, if the care receiver is 
institutionalized or not, co-habitation of care receiver with 
caregiver. We only found a significant relationship for the 
relationship between the caregiver and the care receiver 
and the number of hours of care. However, as mentioned, 
we decided not to include more variables in the model as 
such specific information is unlikely to be generally avail-
able in the clinical trials and this would highly restrict the 
usability of the tool. Lastly, since the iCARE tool predicts 
only the mean hours of care through the health status and 
gender of the patient, the tool is not an appropriate instru-
ment for interventions where other aspects beyond the 
scope of the health of patients can influence care needs; 
for example, interventions that target the location of ser-
vices. For instance, an intervention that reduces the length 
of a hospital stay will have a major impact on the hours 
of informal care but may not directly affect the health of 
the patient, and hence the effect would not be captured by 
our model. Without disregarding these important consid-
erations, the iCARE tool can be used to include informal 
care in economic evaluations based on patients’ EQ-5D 
data in research situations where it is not feasible to col-
lect caregiver data. Furthermore, although the estimates 
are based on relatively weak associations, it is important 
to note that this may pose a problem for predictions at an 
individual level but not so much a problem for estimating 
the mean hours of care within a population of carers, as 
we do here. We recommend using the tool for samples that 
fall within the confidence intervals of the characteristics 
of our samples: men (age range: 47–104.2), women (age 
range: 55–103).
It is worth noting that there are equity implications from 
using different models for estimating caregiver burden for 
male and female patients. However, these are not a conse-
quence of the model developed here, but a consequence of 
including caregiving costs in health economic models in 
general, as these will differ between men and women. For 
example, the Dutch costing manual for productivity losses 
specifies a different hourly wage for men and women, result-
ing in equity implications upon inclusion of productivity 
losses. However not all countries follow such recommenda-
tions. Contrary to the Dutch guidelines, the US guidelines 
do not recommend the use of gender-specific wage rates 
because of potential bias. As such, we acknowledge that the 
developed model here takes into consideration countries 
with similar recommendations to the Netherlands. We rec-
ommend taking this aspect into consideration when using 
the tool.
5  Conclusions
Informal caregivers make an important contribution to soci-
etal welfare. Including caregiving costs in economic evalu-
ations is necessary in order to avoid the risk of labelling 
an intervention as cost effective when it actually does not 
maximize social welfare. This is supported by many national 
guidelines for cost-effectiveness studies advising researchers 
to adopt a societal perspective when identifying the relevant 
costs and effects of an intervention. This study is important 
because it facilitates the inclusion of informal caregiver 
effects in economic evaluations that lack this information. 
However, the algorithm we present is only a ‘second-best’ 
alternative, as actual data on caregivers will obviously be 
more accurate than predictions, and therefore preferable. 
Finally, although one may question the validity of the predic-
tions of a model based on data from the Netherlands when 
used for other countries, the ranges of caregiver time seem 
reasonable, and we would argue that it is better to have a 
reasonable estimate than to completely neglect the effects 
of interventions on informal carers.
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